Transcriptomic Signatures of Zika Virus Infection in Patients and a Cell Culture Model.
Gillian BerglundClaudia D LennonPheonah BaduJohn Andrew BerglundCara T PagerPublished in: Microorganisms (2024)
Zika virus (ZIKV), a re-emerging flavivirus, is associated with devasting developmental and neurological disease outcomes particularly in infants infected in utero. Towards understanding the molecular underpinnings of the unique ZIKV disease pathologies, numerous transcriptome-wide studies have been undertaken. Notably, these studies have overlooked the assimilation of RNA-seq analysis from ZIKV-infected patients with cell culture model systems. In this study we find that ZIKV-infection of human lung adenocarcinoma A549 cells, mirrored both the transcriptional and alternative splicing profiles from previously published RNA-seq data of peripheral blood mononuclear cells collected from pediatric patients during early acute, late acute, and convalescent phases of ZIKV infection. Our analyses show that ZIKV infection in cultured cells correlates with transcriptional changes in patients, while the overlap in alternative splicing profiles was not as extensive. Overall, our data indicate that cell culture model systems support dissection of select molecular changes detected in patients and establishes the groundwork for future studies elucidating the biological implications of alternative splicing during ZIKV infection.
Keyphrases
- zika virus
- rna seq
- end stage renal disease
- single cell
- chronic kidney disease
- newly diagnosed
- ejection fraction
- gene expression
- dengue virus
- endothelial cells
- prognostic factors
- electronic health record
- randomized controlled trial
- cell proliferation
- intensive care unit
- aedes aegypti
- type diabetes
- transcription factor
- oxidative stress
- metabolic syndrome
- patient reported outcomes
- deep learning
- dna methylation
- skeletal muscle
- respiratory failure
- genome wide
- blood brain barrier
- signaling pathway
- extracorporeal membrane oxygenation
- induced pluripotent stem cells
- current status